Results 141 to 150 of about 6,468 (198)

Drug resistance profile of <i>Mycobacterium tuberculosis</i> in China: update until 2024. [PDF]

Front Microbiol
Xu Y, Liu S, Zheng J, Lin J, Gi L, Chang Q.   +5 more
europepmc   +1 more source

Genetic Analysis of Molecular Mechanisms of Drug Resistance in <i>Mycobacterium tuberculosis</i> Against Four Major First-Line Anti-Tuberculosis Drugs (Isoniazid, Rifampin, Ethambutol, and Pyrazinamide). [PDF]

Infect Drug Resist
Roshdi Maleki M.
europepmc   +1 more source

Tissue-specific effects of bacterial PncA overexpression on NAD⁺ metabolism and aging in mice: implications for tissue-specific aging interventions. [PDF]

Front Aging
Huo F, Zhao M, Liu Y, Lv S, Feng S, Guo L, Wang N, Zhang S, Liu Q, Mi T, Wang H, Zhu JK, Liu H.   +12 more
europepmc   +1 more source

Pirazinamide dirençli mycobacterium tuberculosis kompleks kökenlerinde pncA genindeki mutasyonların araştırılması

, 2005
ÖZET Tüberküloz hala dünyada mortalite ve morbiditerıin en önde gelen nedenlerinden biri olarak bilinmektedir. Mycobacterium tuberculosis'ln ilaç direncinden dolayı tüberküloz kontrolü daha zor olmaktadır. Pirazinamid, tüberküloz tedavisi için kullanılan birinci seçenek ilaçlardan biridir.
openaire   +4 more sources

Characterization of Drug Resistance Mutations in <i>Mycobacterium tuberculosis</i> Isolates from Moroccan Patients Using Deeplex Targeted Next-Generation Sequencing. [PDF]

Microorganisms
Laatri S, El Kassimi S, Bentaleb EM, El Messaoudi MD, Irobi J, Belkadi B, Filali-Maltouf A, Ait Benhassou H.   +7 more
europepmc   +1 more source

Machine learning assisted Co₃O₄/NiO popsicle sticks-infused electrospun nanofibers for efficient oxygen evolution reaction. [PDF]

Sci Rep
Al-Ghamdi AA, Sami A, El-Bahy SM, Alsabban MM, Sajjad W, Al-Sulami AI, Waseem Fazal M, Aldahiri RH, Al-Sulami FMH, Khan MA, Akhtar N.   +10 more
europepmc   +1 more source

Genomic characterization of XDR Mycobacterium tuberculosis isolates in Argentina (2006-2015). [PDF]

BMC Infect Dis
Castello FA, Sosa EJ, Campos J, Monteserin J, Poklepovich T, Palumbo MC, Serral F, Messano J, García LG, Simboli N, Turjanski A, Paul R, López B, Matteo M, Palomino MM, Martí M, Fernández Do Porto D.   +16 more
europepmc   +1 more source

Study of the catalytic mechanism of mycobacterium tuberculosis PncA

, 2020
openaire   +1 more source

Mechanism of the dual action self-potentiating antitubercular drug morphazinamide. [PDF]

PNAS Nexus
Ostrer L, Crooks TA, Howe MD, Vo S, Jia Z, Hegde P, Schacht N, Aldrich CC, Baughn AD.   +8 more
europepmc   +1 more source

<i>In silico</i> analysis of the functional implications of drug resistance associated mutations in <i>Mycobacterium tuberculosis</i>. [PDF]

Comput Struct Biotechnol J
Pal A, Pal S, Mahapatra S, Pandey A, Mohanty D.   +4 more
europepmc   +1 more source